These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 2510741)
1. Effect of beraprost sodium on peripheral circulation insufficiency in rats and rabbits. Murai T; Muraoka K; Saga K; Sakai A; Sato N; Amemiya K; Yajima M; Murata T; Umetsu T; Nishio S Arzneimittelforschung; 1989 Aug; 39(8):856-9. PubMed ID: 2510741 [TBL] [Abstract][Full Text] [Related]
2. Effect of beraprost sodium on peripheral circulatory disturbances induced by various stimuli. Nishio S; Yamada N; Endoh T; Isogaya M; Fukatsu Y; Nishimura S; Kanai N; Umetsu T Arzneimittelforschung; 1989 Oct; 39(10):1229-34. PubMed ID: 2514691 [TBL] [Abstract][Full Text] [Related]
3. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects. Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743 [TBL] [Abstract][Full Text] [Related]
4. Effect of isocarbacyclin methyl ester incorporated in lipid microspheres on experimental models of peripheral obstructive disease. Murakami T; Sawada K; Taneda K; Hayashi M; Katsuura Y; Tanabe H; Kiyoki M; Araki H Arzneimittelforschung; 1995 Sep; 45(9):991-4. PubMed ID: 7488320 [TBL] [Abstract][Full Text] [Related]
5. General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system. Murata T; Sakaya S; Hoshino T; Umetsu T; Hirano T; Nishio S Arzneimittelforschung; 1989 Aug; 39(8):860-6. PubMed ID: 2510742 [TBL] [Abstract][Full Text] [Related]
6. Studies on the antiplatelet effect of the stable epoprostenol analogue beraprost sodium and its mechanism of action in rats. Umetsu T; Murata T; Nishio S Arzneimittelforschung; 1989 Jan; 39(1):68-73. PubMed ID: 2541730 [TBL] [Abstract][Full Text] [Related]
7. Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease. Hara H; Shimada H; Kitajima A; Tamao Y Arzneimittelforschung; 1991 Jun; 41(6):616-20. PubMed ID: 1930349 [TBL] [Abstract][Full Text] [Related]
8. Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets. Kajikawa N; Nogimori K; Murata T; Nishio S; Uchiyama S Arzneimittelforschung; 1989 Apr; 39(4):495-9. PubMed ID: 2665758 [TBL] [Abstract][Full Text] [Related]
9. Improvement of walking disturbance by beraprost sodium in rat femoral artery occlusion models. Miyamoto M; Tayama T; Yamaguchi S; Kaneko M; Kurumatani H Eur J Pharmacol; 2006 Sep; 545(2-3):173-6. PubMed ID: 16890936 [TBL] [Abstract][Full Text] [Related]
10. [Cardiovascular effects of beraprost sodium (TRK-100), a prostacyclin analogue in the dog]. Nishio S; Matsuura H; Hattori M; Endoh T; Yamada N; Hirano T; Murai T; Miyao Y; Kanai T; Umetsu T Nihon Yakurigaku Zasshi; 1989 Dec; 94(6):351-61. PubMed ID: 2514128 [TBL] [Abstract][Full Text] [Related]
11. The effects of beraprost Na, a stable prostacyclin analog, on animal models of stroke. Hirano T; Yamori Y; Kanai N; Umetsu T; Nishio S Mol Chem Neuropathol; 1992 Aug; 17(1):91-102. PubMed ID: 1388452 [TBL] [Abstract][Full Text] [Related]
12. Effect of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation. Sim AK; McCraw AP; Cleland ME; Nishio S; Umetsu T Arzneimittelforschung; 1985; 35(12):1816-8. PubMed ID: 3913423 [TBL] [Abstract][Full Text] [Related]
13. Acute effect of beraprost sodium on lower limb circulation in patients with non-insulin-dependent diabetes mellitus-evaluation by color Doppler ultrasonography and laser cutaneous blood flowmetry. Okuda Y; Sone H; Mizutani S; Asano M; Tsurushima Y; Ogawa M; Tada K; Asakura Y; Kawakami Y; Suzuki S; Yamashita K Prostaglandins; 1996 Nov; 52(5):375-84. PubMed ID: 8948505 [TBL] [Abstract][Full Text] [Related]
14. Occlusive thrombosis in the femoral artery of the rabbit: a pharmacological model for evaluating antiplatelet and anticoagulant agents. Sugidachi A; Asai F; Tani Y; Hosokawa T; Koike H Blood Coagul Fibrinolysis; 1996 Jan; 7(1):57-64. PubMed ID: 8845464 [TBL] [Abstract][Full Text] [Related]
15. Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue. Hirasawa Y; Nishio M; Maeda K; Yoshida K; Kita Y Eur J Pharmacol; 1995 Jan; 272(1):39-43. PubMed ID: 7713147 [TBL] [Abstract][Full Text] [Related]
16. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities]. Maksimović ZV Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398 [TBL] [Abstract][Full Text] [Related]
17. Effect of YM-254890, a specific Galphaq/11 inhibitor, on experimental peripheral arterial disease in rats. Uemura T; Takamatsu H; Kawasaki T; Taniguchi M; Yamamoto E; Tomura Y; Uchida W; Miyata K Eur J Pharmacol; 2006 Apr; 536(1-2):154-61. PubMed ID: 16566917 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of OP-41483.alpha-CD, a prostacyclin analog, on peripheral vascular lesion models in rats. Wakitani K; Takakuwa T; Sugioka M; Fujitani B; Aishita H Jpn J Pharmacol; 1992 May; 59(1):57-63. PubMed ID: 1507658 [TBL] [Abstract][Full Text] [Related]
19. Antithrombotic effect of MCI-9042, a new antiplatelet agent on experimental thrombosis models. Hara H; Kitajima A; Shimada H; Tamao Y Thromb Haemost; 1991 Oct; 66(4):484-8. PubMed ID: 1796400 [TBL] [Abstract][Full Text] [Related]
20. Effect of beraprost sodium (TRK-100) on acetic acid-induced skin ulcer. Nishio S; Yamaguchi M; Yamada N; Uenishi N; Kageyama Y; Umetsu T Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):381-93. PubMed ID: 2675230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]